Innovation Articles. App Notes, Case Studies. & White Papers

  1. Developing Non-PEG Stabilizer Lipids For Nucleic Acid Lipid Nanoparticles 7/1/2026

    Non-PEG stabilizer lipids may offer a new path for LNP design. Combining strong colloidal performance with greater chemical flexibility helps address growing concerns around PEG-related immunogenicity.

  2. Neoantigen-Based Personalized Cancer Vaccine 7/1/2026

    Personalized cancer vaccines are advancing quickly, but effective delivery remains a major hurdle. Learn how mRNA and lipid nanoparticle design influence targeting, endosomal escape, and repeat dosing.

  3. Lipid Nanoparticles For Pulmonary Delivery Of mRNA 7/1/2026

    Gain insight into how nebulized mRNA lipid nanoparticles show preclinical success in lung delivery, offering fresh momentum for inhaled gene therapies targeting respiratory diseases.

  4. LNP-Mediated Cell Transfection In Bioreactors Across Workflows 6/24/2026

    Lipid nanoparticles are redefining immune cell engineering. Delve into new data that demonstrates the performance across multiple cell types and bioreactor systems, supporting their potential workflows.

  5. Towards A Universal LNP Platform For Multiplex Engineering 6/19/2026

    Multiplex engineering of T cells for solid tumors requires precise delivery. Emerging LNP approaches enable co-delivery of RNA and DNA, offering a safer, more scalable path beyond viral vectors.

  6. Extrahepatic Delivery Of mRNA-LNP To Spleen 6/19/2026

    In vivo CAR-T approaches aim to reprogram T cells directly in the body using targeted lipid nanoparticles. Improved delivery to immune organs highlights new potential for scalable cell therapies.

  7. mRNA LNPs Drive Safe, Effective Repeat Dosing In Disease Models 6/19/2026

    Repeat dosing may be essential for long-term mRNA applications. Explore safety, immune-response, and efficacy findings from multiple LNP administrations, including a nine-dose evaluation over six months.

  8. Navigating Drug Design In 'Beyond The Rule Of 5' Landscape 6/17/2026

    New drug modalities are transforming treatment but bring new challenges. See how hybrid approaches that combine biologics and chemistry are redefining the design of innovative therapies.

  9. Discovery, Characterization Of Epitope-Diverse MMR Protein Antibodies 6/5/2026

    Learn how these high-affinity, epitope-diverse mAbs provide a powerful toolkit to dissect the role of DNA mismatch repair (MMR) proteins in HD.

  10. Mammalian Expression 5/28/2026

    See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges.